Review
Accepted on 24 Apr 2025
The Key Role of the Ferroptosis Mechanism in Neurological Diseases and Prospects for Targeted Therapy
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1591417
Type at least 3 characters
2,152 articles
Review
Published on 23 Apr 2025
Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1576773
- 331 views
Editorial
Accepted on 22 Apr 2025
Olfactory dysfunction in neurodegenerative diseases
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1611870
- 111 views
Correction
Accepted on 22 Apr 2025
Corrigendum: ErbB4 Preserves Blood-Brain Barrier Integrity via the YAP/PIK3CB Pathway After Subarachnoid Hemorrhage in Rats
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1611574
Review
Accepted on 22 Apr 2025
Biological Engineering Approaches for Modulating the Pathological Microenvironment and Promoting Axonal Regeneration After Spinal Cord Injury
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1574763
Review
Accepted on 21 Apr 2025
The roles of microglia and astrocytes in neuroinflammation of Alzheimer's disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1575453
- 171 views
Clinical Trial
Published on 16 Apr 2025
16 weeks of moderate intensity resistance exercise improves strength but is insufficient to alter brain structure in Gulf War Veterans with chronic musculoskeletal pain: a randomized controlled trial
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1488397
- 554 views
Review
Accepted on 15 Apr 2025
Comparative Analysis of Neuroinflammatory Pathways in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis: Insights into Similarities and Distinctions
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1579511
- 153 views
Original Research
Accepted on 14 Apr 2025
Sweet Spot Mapping and Structural Connectivity in Subthalamic Stimulation: Predicting Neuropsychiatric Outcomes in Parkinson's Disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1577588
- 176 views
Original Research
Accepted on 11 Apr 2025
Peak alpha Frequency and alpha Power Spectral Density as Vulnerability Markers of Cognitive Impairment in Parkinson's Disease: An Exploratory EEG Study
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1575815
- 189 views
Review
Accepted on 10 Apr 2025
Significance of gene therapy in neurodegenerative diseases
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1515255
- 286 views
Editorial
Published on 10 Apr 2025
Editorial: Translational research in hereditary spastic paraplegias: filling the diagnosis gap and therapeutic perspectives
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1595717
- 488 views
Original Research
Accepted on 08 Apr 2025
NFÎşB1: A Common Biomarker Linking Alzheimer's and Parkinson's Disease Pathology
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1589857
- 267 views
Review
Published on 08 Apr 2025
The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1567445
- 905 views
Original Research
Published on 01 Apr 2025
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor function
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1556447
- 778 views
Review
Published on 27 Mar 2025
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2025.1570553
- 1,038 views